Article Text

Download PDFPDF
Pathology of cyclodiode laser: a series of nine enucleated eyes
  1. P A McKelvie1,
  2. M J Walland2
  1. 1Department of Anatomical Pathology, St Vincent's Hospital, Fitzroy, Victoria, Australia
  2. 2Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia
  1. Correspondence to: Penelope McKelvie, Anatomical Pathology, St Vincent's Hospital, 41 Victoria Parade, Fitzroy, Victoria 3065, Australia; mckelvpa{at}svhm.org.au

Abstract

Aim: To study the histological effects of cyclodiode laser treatment in humans, and to compare these findings with the clinical course, treatment response, complications, and indications for enucleation.

Method: Detailed histological examination of nine enucleation specimens was undertaken in conjunction with a retrospective review of patient case notes.

Results: Retreatments had been undertaken in three cases. Although all globes showed damage to pars plicata, intact ciliary processes within the treatment zone were present in all cases. Pars plana injury was also noted in two thirds of cases. Inflammation was mild. Ciliary epithelial proliferation was seen in most cases with increasing time following treatment, in a disorganised pattern, without replication of the ciliary epithelial bilayer. No regeneration of the ciliary processes with fibrovascular cores was found. The three patients with good IOP control at enucleation had all had multiple diode treatments. Neither phthisis nor sympathetic ophthalmia was seen.

Conclusions: Diode laser cyclophotocoagulation produces very characteristic injury to pars plicata, which frequently extends into pars plana, but with only mild persisting inflammation. Ciliary processes are, however, frequently spared within the treatment zone and may account for early or late treatment failure.

  • cyclodestructive procedures
  • cyclodiode
  • cyclophotocoagulation
  • enucleation
  • glaucoma

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • The authors have no proprietary interest related to this paper.